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Otitis media (OM) is the most common childhood disease. Almost all children experience at least one episode, but
morbidity is greatest in children who experience chronic/recurrent OM (COME/ROM). There is mounting evidence
that COME/ROM clusters in families and exhibits substantial heritability. Subjects who had tympanostomy tube
surgery for COME/ROM (probands) and their families were recruited for the present study, and an ear examination
was performed, without knowledge of the subject’s history, to determine presence of OM sequelae. In addition,
tympanometric testing was performed at three frequencies (226, 630 or 710, and 1,400 Hz) to detect abnormal
middle-ear mechanics, and hearing was screened at 20 dB for the speech frequencies. Of these families, 121 had
at least two individuals who had received the diagnosis of COME/ROM (364 affected and genotyped individuals),
of whom 238 affected and informative relative pairs were used for analyses. Single-point nonparametric linkage
analysis provided evidence of linkage of COME/ROM to chromosome 10q at marker D10S212 (LOD 3.78;
) and to chromosome 19q at marker D19S254 (LOD 2.61; ). Analyses conditional55 54Pp 3.0 # 10 Pp 5.3 # 10
on support for linkage at chromosomes 10q and 19q resulted in a signiﬁcant increase in LOD score support on
chromosome 3p (between markers D3S4545 and D3S1259). These results suggest that risk of COME/ROM is
determined by interactions between genes that reside in several candidate regions of the genome and are probably
modulated by other environmental risk factors.
Introduction
Otitis media (OM) is the most common childhood dis-
ease. Almost all children experience at least one episode,
but morbidity is greatest in children who experience
chronic/recurrent OM (COME/ROM). There is mount-
ing evidence that COME/ROM clusters in families and
exhibits substantial heritability. Several studies have re-
ported a greater risk of COME/ROM in children with
a family history of middle-ear disease, which suggests a
genetic component. However, development of COME/
ROM among siblings may be due to inherited biologic
susceptibility, common environmental exposures, or an
interaction between them. Prospective studies have shown
that children whose siblings have a history of COME/
ROM have a 1.6–4.2-fold increase in risk, after con-
trolling for environmental factors (Sipila et al. 1988;
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Teele et al. 1989; Rasmussen 1993). Three twin studies
have reported similar heritability estimates for OM. A
Norwegian population-based sample of 2,750 twin pairs
reported recurrent OM (ROM) heritability of 0.45 and
0.74, respectively, for male and female pairs ascertained
by self-report (Kvaerner et al. 1997). Pittsburgh re-
searchers enrolled 175 same-sex twin or triplet sets and
followed them prospectively, with regular examinations
from birth to age 24 mo (Casselbrant et al. 1999). Her-
itability for the mean proportion of time with otitis me-
dia with effusion (OME) in the ﬁrst 2 years of life was
0.73; discordance for ROM was 0.37 for DZ and 0.04
for MZ pairs. A prospective study of 715 MZ and 658
DZ twin pairs in the United Kingdom examined heri-
tability of OM symptoms at ages 2, 3, and 4 years (Ro-
vers et al. 2002). In the U.K. study, heritability was es-
timated as 0.57 for acute OM and as 0.72 for chronic
airway blockage. Correlation between the total symp-
tom score at age 2 years was 0.90 for MZ twins and
0.65 for DZ twins.
Although there is evidence that OM has a signiﬁcant
genetic component, no genome screens of families with
affected relative pairs have been reported (to our knowl-
edge), and only a few investigators have studied poten-
tial candidate genes for COME/ROM. Cytokines are
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attractive candidates because they play a key role in
OM pathogenesis; genes that control cytokine produc-
tion and function would be expected to be important
in OM susceptibility. A Finnish study reported an asso-
ciation between IL-1a and recurrent OM in children
without a history of allergic rhinitis (Joki-Erkkila¨ et al.
2002). Another Finnish study reported an association
between the surfactant protein A gene locus and sus-
ceptibility to severe respiratory syncytial virus (RSV)
infection (Lo¨fgren et al. 2002) and recurrent acute OM
(Ra¨met et al. 2001). A possible association has been
suggested between surfactant protein D and RSV, which
is an important viral cause of OM (Lahti et al. 2002).
Invasive disease caused by Streptococcus pneumoniae,
the major pathogen implicated in OM, has been linked
to genotypes deﬁned by mutations in codons 52, 54,
and 57 of the mannose binding lectin (MBL) gene and
results in low levels of MBL (Roy et al. 2002). Cases
were 2.6 and 2.0 times more likely than controls to be
homozygous for those variants in the original and con-
ﬁrmatory studies, respectively. The present study was
designed for the investigation of families’ genetic linkage
between COME/ROM and polymorphic DNA markers
at selected sites across the entire human genome, by use
of affected relative pairs.
Material and Methods
Sample Recruitment
Probands (deﬁned as “individuals who had tympanos-
tomy tube surgery for COME/ROM”) and their families
were recruited for the present study. In 2002, we began
identifying probands from past and current studies con-
ducted at the University of Minnesota Otitis Media Re-
search Center between 1992 and 2001 (129 families)
(Daly et al. 1996, 1999; Hunter et al. 1996; Ho et al.
2002) and from the general public (24 families). Of the
129 families recruited from previous studies, 82% of
probands were ascertained from studies in which en-
rollment occurred at the time of tympanostomy tube
treatment, 10% were from a prospective study of infants
treated with tubes, and 8% were identiﬁed by a parent
as having had tube treatment in a cross-sectional hear-
ing-screening study. Of the other 24 families, 67% re-
sponded to posted advertisements, and 33% were re-
cruited from the Children’s Ear and Hearing Clinic at
the University of Minnesota. Ascertainment was broad
based across the studies and included children (1) who
were treated with tubes at ﬁve community hospitals, (2)
who received health care at 17 clinics in a health main-
tenance organization, and (3) who participated in a hear-
ing screening study conducted throughout Minnesota.
Family members were ineligible if they were adopted
or if they had Down syndrome, craniofacial anomaly
(i.e., cleft palate), another genetic disorder with otologic
complications, or tympanostomy tubes for a diagnosis
other than OM. The study was reviewed and approved
annually by the University of Minnesota and Wake For-
est University institutional review boards.
Clinical Evaluation
During a study-speciﬁc visit to the University of Min-
nesota Otolaryngology clinic, family members gavewrit-
ten consent (and, after April 14, 2003, signed a Health
Insurance Portability and Accountability Act authoriza-
tion form). The study neuro-otologist performed an ear
examination, without knowledge of the subject’s history,
to determine presence of OM sequelae; tympanometric
testing was performed at three frequencies (226, 630 or
710, and 1,400 Hz) to detect abnormal middle-ear me-
chanics; hearing was screened at 20 dB for the speech
frequencies; and blood was drawn. Family members pro-
vided information, by questionnaire or interview, about
their OM history, risk factors, and related conditions
and provided medical-record releases. Parents (usually
the mothers) provided history information for their chil-
dren. Trained study personnel abstracted data from the
participants’ medical records regarding OM history, mid-
dle-ear surgery, audiograms, tympanograms, and other
contributing medical problems.
Affected-Status Deﬁnitions
Criteria for determination of phenotype are depicted
in appendix A. An individual was classiﬁed as “affected”
if (1) at least two different data sources indicated a posi-
tive result for the characteristics in appendix A or (2)
one data source indicated a positive result and there was
a speciﬁc middle-ear or tympanometric ﬁnding thought
by experts to be presumptive evidence of a history of
COME/ROM. These ﬁndings included tympanosclerosis,
atrophy, the presence of a tympanostomy tube, choles-
teatoma, static admittance greater than age-referenced
norms, and resonant frequency less than the lowest fre-
quency tested.
There were 692 members (688 in the original data,
an addition of 5 anonymous “fathers” for creation of
half-sib relationships, and a deletion of 1 unrelated sub-
ject) in the 133 pedigrees. Of the 692 members, 76 had
“unknown” disease status, either through insufﬁcient
clinical information or failure to undergo examination.
The remaining 616 individuals were considered as either
“unaffected” or “affected” on the basis of the classiﬁ-
cation schemes discussed above.Whenmeasured by only
the most strict criteria (at least two sources), there were
245 unaffected and 371 affected individuals. Ninety-four
percent were white, and 99% were non-Hispanic.
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Family Sample
Families were eligible for the linkage study if they had
children with concordant and/or discordant histories of
COME/ROM and adequate DNA samples. In the origi-
nal family collection, 153 pedigrees were enumerated.
These pedigrees were ascertained from multiple studies
and included 72 families from the Family Study of Otitis
Media, 34 families from the Long-Term Sequelae of OM
Study, 13 families from the Early OM Study, 10 families
from the Hearing Screening of Minnesota Children, 16
families from the general public, and 8 families of pa-
tients from the Children’s Ear and Hearing Clinic. From
the 153 families that had 692 members with clinical
data, 652 blood samples and 30 buccal samples were
collected. Selection of only those families informative for
linkage resulted in 591 DNA samples, from 133 families,
that were sent to the Center for Inherited Disease Re-
search (CIDR) for a 9-cMgenome screen. These 133 fami-
lies produced 410 affected relative pairs (162 full-sib
pairs, 8 half-sib pairs, 16 grandparent-grandchild pairs,
36 avuncular pairs, 13 ﬁrst-cousin pairs, 17 unrelated
pairs, 3 half-avuncular pairs, and 155 parent-offspring
pairs), 238 of whom were informative.
Genome Scan
DNA extraction was performed by the Molecular Ge-
netics Laboratory Core of the University of Minnesota
General Clinical Research Center. The CIDR performed
a genomewide screen of the 591 samples, by use of 404
ﬂuorescent microsatellite markers. The marker set com-
prised primarily trinucleotide and tetranucleotide repeat
polymorphisms that were based on the Marshﬁeld Ge-
netics version 8 screening set. The average spacing of
the markers was 9 cM, and the largest gap in the marker
panel between adjacent markers was 20 cM; 238,764
genotypes were generated for the study.
Error Checking
The overall missing-data rate was 3.00%, which re-
ﬂects 7,444 missing genotypes from a total of 248,219
(study and quality-control samples), with the exclusion
of three Y chromosome markers. The error rate was
0.07% per genotype, on the basis of 14 different allele
calls from 10,618 paired (quality control) sample events.
Veriﬁcation of reported familial relationships and
marker-error detection was made using PREST (McPeek
and Sun 2000) and PedCheck (O’Connell and Weeks
1998) software. Nine families were identiﬁed as having
segregation problems that were not consistent with re-
ported family structure. Five of those families had a
structure that required changing a full-sib to a half-sib
relationship. Five families (including one with a full-sib–
to–half-sib relationship change) required other structure
changes. After these family structure problems were re-
solved, 236 marker genotypes were designated as “miss-
ing.” The 236 marker problems occurred in 233 indi-
viduals, with distribution across the genome (no one
marker had to be excluded).
NPL Analysis
All genetic analyses were performed on the family data
with the multiple classiﬁcations of affected status. Since
all genetic-analysis results were similar in their support
for linkage, with only minor deviations in magnitude of
support, we present as affected only those that reported
two or more sources of evidence, from the clinical or
tympanogram ﬁndings.
Single- and multipoint-linkage analyses (based on the
consensus map order and distances) were performed us-
ing GeneHunter-plus and GeneHunter-NPL software
(Kruglyak et al 1996; Kong and Cox 1997; Langefeld
et al 2001). Multipoint-linkage analysis was performed
using the S(pairs) option of GeneHunter-plus, and maxi-
mized LOD scores were calculated under an exponential
model, with d constrained between 0 and 2.
Stratiﬁed (conditional) analyses were performed using
GeneHunter-plus (Kong and Cox 1997), to examine epi-
static effects among the candidate chromosomal regions
linked with COME/ROM. Tomodel epistasis (gene-gene
interaction), a series of analyses was performed in which
each family was assigned a “weight.” The weight as-
signed to each family, either 0 or 1, for each region was
based on the evidence of linkage, as reﬂected by the
maximum-multipoint-likelihood-ratio Z score (Zlr) in
that region. To model epistasis, a weight of 1 was as-
signed to families with a maximum multipoint Z 1 0lr
at that location, with a corresponding weight of 0 as-
signed to all others. Only families that received a weight
of 1 contributed to the resultant LOD scores. LOD
scores that increased by at least 1.18 (corresponding to
) were considered as suggestive for epistasis.Pp .01
Parametric Linkage Analysis
Parametric LOD scores were calculated, using Gene-
Hunter software (Kruglyak et al 1996), for individual
markers on chromosomes 10 and 19. Analyses were per-
formed using a recessive model and a dominant model
for transmission of COME/ROM susceptibility. Each
model included reduced penetrance for the “at risk” ge-
notypes and sporadic rates for the “not at risk” geno-
types. Each model produced the equivalent population
prevalence of COME/ROM. Thus, the recessive model
had COME/ROM allele frequency of 0.40, with 5%
sporadic frequency and 95% penetrance of the “at risk”
homozygote. The dominant model had COME/ROM
allele frequency of 0.10, with 80% penetrance of the
“at risk” genotypes and 5% penetrance of the sporadic
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Table 1
Characteristics of Study Families
RISK FACTOR
NO./TOTAL (%) OF FAMILY MEMBERS WITH SPECIFIED RISK FACTOR WHO WERE
Phenotyped
( )np 616
Phenotyped and
DNA Sampled
( )np 588
Affected
( )np 371
Unaffected
( )np 245
Preschool day care 313/612 (51.1) 309/585 (52.8) 237/369 (64.2) 76/243 (31.3)
Exclusively formula fed 241/581 (41.5) 234/561 (41.7) 134/361 (37.1) 107/220 (48.6)
Parental smoking 302/613 (49.3) 283/588 (48.1) 163/370 (44.1) 139/243 (57.2)
cases. Parametric analyses were performed using the het-
erogeneity parameter, a, that represented the proportion
of families with linkage at that speciﬁc marker, which
resulted in a heterogeneity LOD score (HLOD).
Empirical Signiﬁcance Levels
Empirical P values for regions of interest were deter-
mined by simulation of Mendelian transmission for fami-
lies, by use of marker allele frequencies observed in the
sample. The percentage of LOD scores that were greater
than the nominal value, on the basis of simulations (at
least 10,000 replicates, depending on the magnitude of
the observed LOD), provided the estimated empirical P
value. Empirical P values for stratiﬁed (conditional) an-
alyses were estimated by permutation of the weight as-
signed to each family while the number of families that
were included in any one analysis were maintained.
Results
Risk-factor characteristics of study families withCOME/
ROM are summarized in table 1. The agreement be-
tween reported OM history and other data sources was
examined for subgroups. For parents with a positive
history of COME/ROM, agreement with examwas 73%
and, with tympanogram, agreement was 61%. Eight per-
cent of parents had missing OM history data. Agreement
did not differ by sex, age, or education. For reported
sibling OM history, agreement with exam was 65%,
agreement with tympanogram was 66%, and agreement
with medical records was 73%. Only 1% of siblings had
missing OM history data. Among siblings, agreement
between data sources did not differ by age, sex, or num-
ber of siblings. If OM history was positive, there was at
least one other positive data source for 67% of parents
and 83% of siblings. If OM history was negative, all
other sources were negative for 60% of parents and 53%
of siblings.
Single-Point NPL Analysis
Single-point NPL analyses were performed. The NPL
Z scores were converted to LOD scores by use of allele-
sharing-modeling software (Kong and Cox 1997). This
analyses identiﬁed seven regions in the genome in which
at least one marker had a LOD score 11—on chromo-
somes 5p, 10q, 12p, 14q, 18q (two locations), and 19q.
There was signiﬁcant evidence of linkage toCOME/ROM
on chromosome 10q at marker D10S212 (LOD 3.78;
). There was also suggestive evidence of5Pp 3.0 # 10
linkage to COME/ROM on chromosome 19q at marker
D19S254 (LOD 2.61; ). No other loca-4Pp 5.3 # 10
tion exhibited a LOD score 11.17 for any region.
Multipoint NPL Analysis
Multipoint NPL analyses (ﬁgs. 1 and A1) provided
evidence of linkage to COME/ROM similar to that ob-
served in the single-point analyses. The strongest evi-
dence of linkage to COME/ROM occurred on chro-
mosome 19q (LOD 2.53; ) near marker4Pp 6.4 # 10
D19S254 (ﬁg. 2). This support was similar to that ob-
served in the single-point analysis (LOD 2.61 at marker
D19S254). One other location in the genome had a mul-
tipoint LOD score 11, on chromosome 10q (LOD 1.64;
) near marker D10S212 (ﬁg. 3). The evidencePp .0064
that supports linkage on 10q decreased dramatically from
that observed in the single-point analysis (LOD 3.78).
The observed concordance with respect to location (if
not exact LOD score support) between the single-point
and the multipoint analyses suggests that the linkage to
COME/ROM for these regions may be real and may not
represent artifacts generated by genotyping errors.
Empirical Signiﬁcance Levels
We used simulation of genotypes and gene dropping
of genotypes under assumed Mendelian transmission to
estimate genomewide P values for the observed multi-
point-linkage results. The probability of observing a
LOD score 11.64 (support on chromosome 10q) by
chance was (empirical LOD 1.63). The prob-33.1 # 10
ability of observing a LOD score 12.53 (support on chro-
mosome 19q) by chance was (empirical LOD43.9 # 10
2.46).
Parametric Linkage Analysis
Parametric LOD scores were calculated for markers
on chromosomes 10 and 19, since these locations exhib-
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Figure 1 Genome scan for COME/ROM
ited the strongest evidence of linkage to COME/ROM in
both single-point and multipoint analyses. There have
been few segregation analyses of COME/ROM in the
literature, but the most compelling evidence is that the
contribution of a single major gene inﬂuences both re-
cessive and dominant modes of inheritance. Analyses
were performed both with and without a parameter that
allows for heterogeneity of linkage support (with the
parameter a representing the proportion of linked fami-
lies). For chromosome 10, in single-marker analyses, the
strongest evidence of linkage was observed for marker
D10S212 (HLOD 2.36; ) under the recessiveap 0.42
model and at the same location (HLOD 1.51; ap
) under the dominant model. For chromosome 19,0.51
the strongest single-point evidence was observed for
marker D19S591 (HLOD 1.31; ) under theap 0.28
recessive model and for marker D19S254 (HLOD 0.70;
) under the dominant model. It should be notedap 0.32
that the maximum HLOD for chromosome 19 under
the recessive model (at marker D19S591) was at the
pter location, whereas the maximum HLOD under the
dominant model (at marker D19S254) was at the qter
location. Differences in magnitude of linkage support
between multipoint and two-point analyses could be due
to reduced information content of the markers at the
telomeric end of 10q (52%).
Conditional Analysis
We performed conditional analyses by stratifying fami-
lies ﬁrst into those that supported linkage at 10q and
then at 19q and by observing whether regions of the
genome exhibited a signiﬁcant increase in support of
linkage for COME/ROM. There was signiﬁcant overlap
in the families that supported linkage at 10q and at 19q,
so the regions (if any existed) that had potential inter-
action effects were expected to be similar. When analy-
ses were performed, a region on 3p (between markers
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Figure 2 Linkage analysis of COME/ROM on chromosome 19, with NPL scores for both multipoint (solid line) and single-point (individual
points) approaches.
D3S4545 and D3S1259 at 32 cM) exhibited increased
support for linkage (unconditional LOD 0.60; con-
ditional [10q] LOD 2.43; conditional [19q] LOD
1.84). It should be noted that D3S1259 is ∼8 cM from
D3S3038, a marker that has a single-point HLOD of
1.03 by use of a parametric (recessive) model. Together,
these results suggested an interaction between 10q with
3p and between 19q with 3p.
Phenotypic Correlations
There was the appearance of signiﬁcant overlap in the
families that supported linkage of COME/ROM to 10q
and 19q. Of the entire set of 133 families, 18 families
supported linkage (LOD 10) for only 19q, 25 families
supported linkage only for 10q, 38 families supported
linkage at both 10q and 19q, and 52 families failed to
provide evidence of linkage at either of the two primary
locations. There were 36 families that supported both
3p and 10q linkage, and there were 31 families that
supported both 3p and 19q linkage; 26 of these families
supported linkage to all three locations.
Among all families supporting linkage at one or both
of the 10q or 19q locations, 63.0% had more than one
family member with a history of tympanostomy tubes
(indication of more severe or chronic disease), compared
with 36.5% in the families that did not support linkage
at these sites ( ). The median number of affectedPp .003
relatives in the families supporting linkage was approxi-
mately three, compared with two affected relatives in
families not supporting linkage ( ).Pp .009
Factors known to be associated with increased risk of
COME/ROM in epidemiologic studies were character-
ized in family members, with respect to evidence of fam-
ily-linkage (to either 10q or 19q) support. The propor-
tion of family members exposed to exclusive formula
feeding was 38.2% in families with linkage, compared
with 47.2% in families not supporting linkage (Pp
). The proportion of families with smokers in the.043
household was 48.5%, comparedwith 51.1% in families
that failed to support linkage ( ). The propor-Pp .585
tion of families that employed day care in early child-
hood was 52.2% in the families with linkage, compared
with 49.3% in families not supporting linkage (Pp
)..555
Discussion
We report the initial genome scan performed for one of
the most common chronic disorders in children, COME/
ROM. Our sample of families with COME/ROM was
enriched with multiple cases, probably those with se-
verity greater than average, and with sufﬁcient evidence
that older family members still have evidence of COME/
ROM years after the event. However, there is no simple
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Figure 3 Linkage analysis of COME/ROM on chromosome 10, with NPL scores for both multipoint (solid line) and single-point (individual
points) approaches.
diagnostic test for determination of COME/ROM his-
tory. Although younger children are likely to have better
agreement between data sources because OM is a disease
of early childhood, it is necessary to provide phenotype
data for family members of all ages. Affected status was
based on data from four sources, to increase the likeli-
hood of accurate phenotyping. All sources are imperfect:
history may not be accurately remembered, those with
a recurrent OM history are less likely to have deﬁnitive
changes in the tympanic membrane and middle ear than
those who received tubes, and, for older children and
(especially) adults, it is a challenge to obtain a pertinent
medical record for early childhood. Because of these lim-
itations, some over- and underclassiﬁcation of affection
status may have occurred.
Our results suggest that relatively few genetic loca-
tions may be involved in susceptibility to COME/ROM.
Overall, we identiﬁed several regions that support link-
age by use of both single- and multipoint NPL analyses
on chromosomes 10q and 19q. When conditional analy-
ses were employed, a potential region on chromosome
3p was observed to interact with those on 10q and 19q.
Analyses of these data by parametricmethods conﬁrmed
the contribution of 10q, provided limited support for an
independent effect on 19q, and supported a role for a
region on 3p.
The current model for the development of COME/
ROM proposes that an initial viral infection is followed
by a bacterial infection; progression is dependent on
genetically determined anatomical and immunological
factors that lead to impairment of ciliary function in
the middle ear. Ultimately, there is an establishment of
a bacterial bioﬁlm, which may be a factor in the persis-
tence of infection and effusion (Ehrlich and Post 1999).
Central to this model is the immunological response to
the initial viral infection and to the secondary bacterial
persistence and, therefore, to the exacerbation of the
inﬂammatory state. The three candidate regions for OM
identiﬁed in this study contain plausible candidate genes
involved in defense responses or in the modulation of
the inﬂammatory response. Other candidates may be
unrecognized, and the support intervals for the regions
remain broad and not precisely deﬁned; therefore, the
identity of the “true” positional candidates remains
unresolved.
The COME/ROM susceptibility region in 19q
(19q13.42-q13.43) contains 1100 annotated genes (Uni-
versity of California–Santa Cruz [UCSC] Genome Bio-
informatics), many of which code for predicted proteins
with unknown function. Among the characterized genes,
the region includes the∼1-Mb leukocyte receptor cluster
(LRC), which contains the genes encoding 12 killer cell
immunoglobulin (IG)-like receptors (KIR) as well as 13
IG-like transcripts (ILTs) (Andre´ et al. 2001). KIR pro-
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teins negatively regulate the cytotoxic activity of natural
killer cells and subsets of T cells, whereas the closely
related ILT proteins are expressed in lymphoid andmye-
lomonocytic cells (Andre´ et al. 2001). Members of the
LRC prevent the activation of immune cells by inter-
action with speciﬁc ligands, such as major histocom-
patibility complex (MHC) class I molecules. It is note-
worthy that, like the MHC, the LRC is highly poly-
morphic, not only at the level of gene alleles but also
in the number of KIR and ILT genes that are encoded
in the cluster (Wilson et al. 2000).
The second COME/ROM region on 10q (10q26.3)
encodes 11 characterized genes and at least 17 predicted
genes (UCSC Genome Bioinformatics). Because of the
similarities between the pulmonary and middle-ear epi-
thelia in their response to xenobiotic agents, a plausible
candidate gene for COME/ROM in this region is the
ADAM8 gene, a member of the ADAM (a disintegrin
and metalloproteinase domain) family of proteins that
contain the catalytic site of a metalloprotease and an
anti-integrin domain (Yamamoto et al. 1999). Recently,
ADAM8 was identiﬁed as an allergen-induced asthma
gene (King et al. 2004) and has been shown to convert
membrane-bound CD23 into a soluble form that regu-
lates IgE synthesis, macrophage activation, and inﬂam-
mation. Although several candidate genes (SFTPA1 and
MBL2) have been mapped to 10q, the support interval
for linkage on 10q in the present study was at the telo-
mere, quite distinct from the positions of SFTPA1 and
MBL2.
The region in 3p25.3 that is putatively involved in a
gene-gene interaction with the two previous regions (10q
and 19q) includes two interesting candidate genes for
COME/ROM—histamine receptor H1 (HRH1) and in-
terleukin-1 (IL-1) receptor activated kinase 2 (IRAK2).
HRH1 codes for a G protein–coupled receptor that me-
diates some of the actions of the inﬂammatory mediator,
histamine (Yamashita et al. 1991). Mice that lack Hrh-
1 show suppression of interferon g and increased se-
cretion of the T helper cytokines IL-4 and IL-13, as well
as higher levels of antigen-speciﬁc IgG1 and IgE com-
pared with wild-type mice, which suggests that HRH1
modulates the effect of histamine on T cell–mediated
immune response (Jutel et al. 2001). IRAK2 is a com-
ponent of the signal transduction complex that is re-
cruited to the IL-1 and Toll-like family of receptor com-
plexes (Janssens and Beyaert 2003) upon binding of
their ligands, which ultimately results in the activation
of the NF-kB transcription factor, a known inducer of
inﬂammatory gene expression. It should be recognized,
however, that the power of the conditional analyses is
less than that of the original linkage analyses, because
of the stratiﬁcation of the families into subsets on the
basis of the support for COME/ROM linkage at 10q
and 19q. Thus, these results should be viewed with
caution.
In summary, these results suggest that the genetic sus-
ceptibility to COME/ROM is determined, in part, by
the contribution of genes in three distinct chromosomal
regions (10q, 19q, and 3p), with potential gene-gene
interaction. These regions of linkage contain several pu-
tative positional candidate genes, including those in-
volved with inﬂammation and response to environmen-
tal pathogens. Replication of these ﬁndings in this and
other populations as well as in targeted molecular stud-
ies will further reﬁne the genetic cause of this most com-
mon chronic disease of childhood.
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Appendix A
Criteria for Classiﬁcation of Family Members
as “Affected with COME/ROM”
Ear examination: Evidence of a positive history for
COME/ROMwas based on one or more of the following:
1. retraction,
2. perforation,
3. atrophy,
4. drainage,
5. tympanosclerosis,
6. tympanostomy tube,
7. cholesteatoma, and
8. monomer.
Tympanogram*: Family members were considered af-
fected if there was presence of one or more the following:
1. Age 110 years,
A. Y1! 0.4 or Y111.7 mmho,
B. TW2180 decaPascals (daPa),
C. resonant frequency !630 or 11,400 Hz, and
D. abnormal van Huyse pattern at 630 or 1,400
Hz.
2. Age 10 years,
* Y1 p static admittance. TW2 p tympanic membrane width.
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A. Y1!0.4 or Y111.0 mmho,
B. TW2160 daPa,
C. resonant frequency !710 or 11,400 Hz, and
D. abnormal van Huyse pattern at 710 or 1,400
Hz.
Self-reported history of one or more of the following:
1. history of tympanostomy tubes, three or more OM
episodes in 1 year, or six episodes before age 6 years,
2. tympanic membrane (TM) perforation,
3. mastoidectomy,
4. otorrhea,
5. cholesteatoma,
6. tympanosclerosisy, and
7. tympanoplasty.
Medical record of presence of one or more of the fol-
lowing:
1. tympanostomy tubes,
2. otorrhea,
3. OME 12 mo,
4. TM perforation,
5. cholesteatoma,
6. tympanoplasty, and
7. three or more episodes of OM in 1 year or six
episodes before age 6 years.
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